A detailed history of High Falls Advisors, Inc transactions in Amgen Inc stock. As of the latest transaction made, High Falls Advisors, Inc holds 1,490 shares of AMGN stock, worth $470,840. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,490
Previous 1,390 7.19%
Holding current value
$470,840
Previous $395,000 17.72%
% of portfolio
0.12%
Previous 0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$262.75 - $319.31 $26,275 - $31,931
100 Added 7.19%
1,490 $465,000
Q4 2023

Feb 15, 2024

SELL
$255.7 - $288.46 $51,140 - $57,691
-200 Reduced 12.58%
1,390 $400,000
Q3 2023

Nov 15, 2023

BUY
$218.65 - $271.46 $21,865 - $27,145
100 Added 6.71%
1,590 $427,000
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $171,772 - $218,257
-750 Reduced 33.48%
1,490 $391,000
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $69,213 - $77,022
-300 Reduced 11.81%
2,240 $545,000
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $1,096 - $1,212
-5 Reduced 0.2%
2,540 $614,000
Q4 2021

Feb 15, 2022

SELL
$198.88 - $227.6 $8,750 - $10,014
-44 Reduced 1.7%
2,545 $572,000
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $212 - $248
1 Added 0.04%
2,589 $551,000
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $221 - $258
1 Added 0.04%
2,588 $644,000
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $559,775 - $666,592
2,587 New
2,587 $594,000
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $690,105 - $767,453
-2,941 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $197 - $242
1 Added 0.03%
2,941 $694,000
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $182 - $241
1 Added 0.03%
2,940 $596,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $189 - $243
1 Added 0.03%
2,939 $708,000
Q3 2019

Nov 21, 2019

BUY
$174.11 - $208.62 $174 - $208
1 Added 0.03%
2,938 $568,000
Q2 2019

Aug 15, 2019

SELL
$166.7 - $195.41 $4,167 - $4,885
-25 Reduced 0.84%
2,937 $541,000
Q1 2019

May 16, 2019

BUY
$180.87 - $203.88 $5,064 - $5,708
28 Added 0.95%
2,962 $563,000
Q4 2018

Feb 15, 2019

SELL
$178.4 - $208.25 $15,342 - $17,909
-86 Reduced 2.85%
2,934 $571,000
Q3 2018

Nov 16, 2018

SELL
$185.29 - $208.89 $159,719 - $180,063
-862 Reduced 22.21%
3,020 $626,000
Q2 2018

Aug 15, 2018

SELL
$166.05 - $186.51 $42,508 - $47,746
-256 Reduced 6.19%
3,882 $717,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $7,963 - $9,306
-47 Reduced 1.12%
4,138 $705,000
Q4 2017

Feb 16, 2018

SELL
$168.79 - $188.59 $39,328 - $43,941
-233 Reduced 5.27%
4,185 $728,000
Q3 2017

Nov 15, 2017

BUY
$167.29 - $191.0 $739,087 - $843,838
4,418
4,418 $824,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track High Falls Advisors, Inc Portfolio

Follow High Falls Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Falls Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on High Falls Advisors, Inc with notifications on news.